Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project

F.H. Blackhall, S. Peters, L. Bubendorf, U. Dafni, K.M. Kerr, H. Hager, A. Soltermann, K.J. O'Byrne, C. Dooms, A. Sejda, J. Hernandez-Losa, A. Marchetti, S. Savic, Q. Tan, E. Thunnissen, E.J.M. Speel, R. Cheney, D. Nonaka, J. de Jong, M. MartorellI. Letovanec, R Rosell, R.A. Stahel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2780-2787
JournalJournal of Clinical Oncology
Volume32
Issue number25
DOIs
Publication statusPublished - 2014

Cite this